The Hsp90 Inhibitor IPI-504 Overcomes Bortezomib Resistance in Mantle Cell Lymphoma in Vitro and in Vivo by Down-Regulation of the Prosurvival ER Chaperone BiP/Grp78

Blood - United States
doi 10.1182/blood-2010-04-278853
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Bortezomib Prevents Development of Cytarabine Resistance in a Mantle Cell Lymphoma in Vitro Model

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

CDK5 Inhibition In�vitro and in Vivo Induces Cell Death In�myeloma and Overcomes the Obstacle of Bortezomib Resistance

International Journal of Molecular Medicine
MedicineGenetics
2020English

In Vitro and in Vivo Activity of a New Small-Molecule Inhibitor of HDAC6 in Mantle Cell Lymphoma

Haematologica
Hematology
2018English

The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible Treatment

Frontiers in Pharmacology
Pharmacology
2013English

Cell Surface Relocalization of the Endoplasmic Reticulum Chaperone and Unfolded Protein Response Regulator GRP78/BiP

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Sorafenib Inhibits Cell Migration and Stroma-Mediated Bortezomib Resistance by Interfering B-Cell Receptor Signaling and Protein Translation in Mantle Cell Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Effects of the Proteasome Inhibitor Bortezomib in Combination With Chemotherapy for the Treatment of Mantle Cell Lymphoma: A Meta-Analysis

Turkish Journal of Haematology
Hematology
2019English

Nelfinavir Augments Proteasome Inhibition by Bortezomib in Myeloma Cells and Overcomes Bortezomib and Carfilzomib Resistance

Blood Cancer Journal
OncologyHematology
2013English

BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma

Community Oncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy